Results 221 to 230 of about 946,861 (341)

Prevalence and associated factors of anemia during pregnancy at a tertiary hospital in Zambia. [PDF]

PLoS One
Siame L, Chishimba FL, Mukubesa C, Musonda M, Kabati F, Miyoba MH, Kamvuma K, Masenga SK, Hamooya BM.   +8 more
europepmc   +1 more source

Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE ...
Naïm Bouazza, Michaela Semeraro, Gabrielle Lui, Léo Froelicher‐Bournaud, Laure Choupeaux, Jean‐Marc Treluyer, Sihem Benaboud, Joelle Terzic, Eric Hachulla, Philippe Remy, Jérôme Harambat, Alexandre Karras, Caroline Rousset‐Rouviere, Anne Jolivot, Zahir Amoura, Eric Daugas, Aurélie Hummel, Rémi Salomon, Jean‐Christophe Lega, Stéphane Decramer, Alexandre Belot, Delphine Gobert, Nathalie Costedoat‐Chalumeau, Stanislas Faguer, Isabelle Melki, Noémie Jourde‐Chiche, Brigitte Bader‐Meunier   +26 more
wiley   +1 more source

Determinants of Anemia Among Patients with Chronic Kidney Disease: A Systematic Review of Empirical Evidence. [PDF]

J Multidiscip Healthc
Prapaiwong P, Ruksakulpiwat S, Jariyasakulwong P, Kasetkala P, Puwarawuttipanit W, Pongsuwun K.   +5 more
europepmc   +1 more source

The Experimental Production of Splenomegaly, Anemia and Leukopenia in Albino Rats [PDF]

, 1953
Jeffress G. Palmer, E. J. Eichwald, G. E. Cartwright, M. M. Wintrobe   +3 more
openalex   +1 more source

Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia‐inducible factor‐2α inhibitor, in healthy participants

British Journal of Clinical Pharmacology, EarlyView.
Aims Casdatifan is an orally bioavailable small‐molecule hypoxia‐inducible factor‐2α (HIF‐2α) inhibitor currently in development for treating patients with clear cell renal cell carcinomas. The aim of this study was to characterize the pharmacokinetics (PK), pharmacodynamics and safety of casdatifan in healthy participants.
Mohammad Ghasemi, Ji Yun Kim, Lisa Seitz, Lixia Jin, Paul G. Foster, Kai H. Liao, Tzuling Cheng, Elaine Paterson, Maria Velinova, Nicole Rivera Rosario, Reza Khosravan, Balaji Agoram   +11 more
wiley   +1 more source

Development of Interarterial Coronary Anastomoses by Chronic Anemia. Disappearance Following Correction of Anemia [PDF]

, 1955
RICHARD W. ECKSTEIN
openalex   +1 more source

Anemia and Transfusion in Infective Endocarditis. [PDF]

Rev Cardiovasc Med
Alberts T, Eberl S, van der Vaart TW, Boekholdt SM, Hermanns H.   +4 more
europepmc   +1 more source

Reticulocytopenia in Autoimmune Hemolytic Anemia [PDF]

, 1956
William H. Crosby, Henry Rappaport
openalex   +1 more source

Transcription‐Replication Conflicts: Unlocking New Frontiers in Cancer

BioEssays, Volume 47, Issue 8, August 2025.
Transcription‐replication conflicts (TRCs) constitute a major source of genome instability. Such conflicts are regulated by chromatin, its dysfunction causing replication stress, DNA breaks, and mutations frequently found in cancer. We review the molecular basis of TRCs and chromatin regulation and discuss the clinical potential of targeting TRCs as ...
Aleix Bayona‐Feliu, Andrés Aguilera
wiley   +1 more source

Prevalence and associated factors of at risk of anemia among children under five in Northeast Thailand using noninvasive hemoglobin screening in a cross sectional study. [PDF]

Sci Rep
Saengnipanthkul S, Sirikarn P, Musikaboonleart S, Tran LC, Puwanant M.   +4 more
europepmc   +1 more source